INTRODUCTIONParents have found the transition to adulthood for their sons or daughters with intellectual and/or developmental disabilities (IDD) particularly challenging. The literature has not examined how parents work together and with others in face of this transition nor has it highlighted parental goals in this process. This study used a perspective based on joint, goal‐direct action to describe the projects that Canadian parents engaged in together and with others relative to this transition.MethodsUsing the qualitative action‐project method, joint projects between parents and with others were identified from their conversations and followed for 6 months.FindingsThree groups of projects were described: equipping the young adult for adult life, connecting for personal support and managing day‐to‐day while planning for the future.ConclusionsParents act together and with others relative to the transition to adulthood of their young adult children with IDD. These projects are complex and differ in goals, steps, resources and emotional regulation and motivation.
rologue: Globalization, globality, globe-stone / Patrick Chamoiseau --. - Introduction / Eva Sansavior and Richard Scholar --. - The archipelago goes global: late Glissant and the early modern isolario / Richard Scholar --. - How globalization invented Indians in the Caribbean / Patricia Seed --. - Precocious modernity: environmental change in the early Caribbean / Philip D. Morgan --. - 'Slaves' in my family: French modes of servitude in the New World / Christopher L. Miller --. - Paradoxical encounters: the essay as a space of globalization in Montaigne's 'Des cannibales' and Maryse Condé's "O brave new world' / Eva Sansavior --. - Tobacco: the commodification of the Caribbean and the origins of globalization / Guillaume Pigeard de Gurbert --. - The amaranth paradigm: Amerindian indigenous glocality in the Caribbean / Judith Misrahi-Barak --. - Aluminium: globalizing Caribbean mobilities, Caribbeanizing global mobilities / Mimi Sheller --. - Race and modernity in Hispaniola: tropical matters and development perspectives / David Howard --. - Local, national, regional, global: Glissant and the postcolonial manifesto / Charles Forsdick --. - Tropical apocalypse: globalization and the Caribbean end times / Martin Munro
Frontmatter -- CONTENTS -- PREFACE -- Introduction TARTAN, TARTANRY AND HYBRIDITY -- 1 GHEIBHTE BREACAIN CHARNAID ('SCARLET TARTANS WOULD BE GOT . . .'): THE RE-INVENTION OF TRADITION -- 2 PLAIDING THE INVENTION OF SCOTLAND -- 3 FROM DAVID STEWART TO ANDY STEWART: THE INVENTION AND RE-INVENTION OF THE SCOTTISH SOLDIER -- 4 PAYING FOR THE PLAID: SCOTTISH GAELIC IDENTITY POLITICS IN NINETEENTHCENTURY NORTH AMERICA -- 5 TARTANRY INTO TARTAN: HERITAGE, TOURISM AND MATERIAL CULTURE -- 6 MYTH, POLITICAL CARICATURE AND MONSTERING THE TARTAN -- 7 TARTANRY AND ITS DISCONTENTS: THE IDEA OF POPULAR SCOTTISHNESS -- 8 'WHA'S LIKE US?': ETHNIC REPRESENTATION IN MUSIC HALL AND POPULAR THEATRE AND THE REMAKING OF URBAN SCOTTISH SOCIETY -- 9 LITERARY TARTANRY AS TRANSLATION -- 10 LOOKING AT TARTAN IN FILM: HISTORY, IDENTITY AND SPECTACLE -- 11 TARTAN COMICS AND COMIC TARTANRY -- 12 ROCK, POP AND TARTAN -- 13 CLASS WARRIORS OR GENEROUS MEN IN SKIRTS? THE TARTAN ARMY IN THE SCOTTISH AND FOREIGN PRESS -- 14 DON'T TAKE THE HIGH ROAD: TARTANRY AND ITS CRITICS -- BIBLIOGRAPHY -- NOTES ON THE CONTRIBUTORS -- INDEX
Zugriffsoptionen:
Die folgenden Links führen aus den jeweiligen lokalen Bibliotheken zum Volltext:
We are grateful to members of the genomics core facility (PF2, Génopole) for the availability of the microarray scanner and the Alain Jacquier's lab for making the GenePix software available. We are grateful to Drs. Suzanne Noble and Aaron Mitchell for providing C. albicans mutant collections. We thank all members of the Fungal Biology & Pathogenicity Unit, particularly Drs. Anne Neville and Adeline Feri for their numerous insights during the course of this project. This work has been supported by grants from the Agence Nationale de la Recherche (KANJI, ANR-08-MIE-033-01 to C.d'E. and F.D.; ERA-Net Infect-ERA, FUNCOMPATH, ANR-14-IFEC-0004; and CANDIHUB, ANR-14-CE-0018 to C.d'E.), the French Government's Investissement d'Avenir program (Laboratoire d'Excellence Integrative Biology of Emerging Infectious Diseases, ANR-10-LABX-62-IBEID to C.d'E.; Institut de Recherche Technologique BIOASTER, ANR-10-AIRT-03 to C.d'E., F.D. and T.J.), the European Commission (FinSysB PITN-GA-2008-214004 to C.d'E.) and the Wellcome Trust (The Candida albicans ORFeome project, WT088858MA to C.d'E. and C.M.). C.M. acknowledges support from the Medical Research Council, UK (New Investigator Award, G0400284), the MRC Centre for Medical Mycology (MR/N006364/1) and the University of Aberdeen. S.Z. is an Institut Pasteur International Network Affiliate Program Fellow. S.Z., L.v.W. and A.H.C. were the recipients of post-doctoral fellowships from the European Commission (FINSysB, PITN-GA-2008-214004 to S.Z.), the Agence Nationale de la Recherche (KANJI, ANR-08-MIE-033-01 to S.Z.; ERA-Net Infect-ERA, FUNCOMPATH, ANR-14-IFEC-0004 to A.H.C.; CANDIHUB, ANR-14-CE-0018 to L.v.W) and the French Government's Investissement d'Avenir program (Institut de Recherche Technologique BIOASTER, ANR-10-AIRT-03 to S.Z. and A.H.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. ; Peer reviewed ; Publisher PDF
Resistively heated diamond-anvil cells have been used together with synchrotron x-ray diffraction to investigate the phase diagram of calcium up to 50 GPa and 800 K. The phase boundaries between the Ca-I (fcc), Ca-II (bcc), and Ca-III (simple cubic, sc) phases have been determined at these pressure-temperature conditions, and the ambient temperature equation of state has been generated. The equation of state parameters at ambient temperature have been determined from the experimental compression curve of the observed phases by using third-order Birch-Murnaghan and Vinet equations. A thermal equation of state was also determined for Ca-I and Ca-II by combining the room-temperature Birch-Murnaghan equation of state with a Berman-type thermal expansion model. ; Part of the research was supported by the Spanish Government MINECO under Grants No. MAT2016-75586-C4-1/4P and No. MAT2015-71070-REDC. ; Peer reviewed
In: Hutchinson , S J , Dillon , J F , Fox , R , McDonald , S A , Innes , H A , Weir , A , McLeod , A , Aspinall , E J , Palmateer , N E , Taylor , A , Munro , A , Valerio , H , Brown , G & Goldberg , D J 2015 , ' Expansion of HCV treatment access to people who have injected drugs through effective translation of research into public health policy : Scotland's experience ' International Journal of Drug Policy , vol 26 , no. 11 , pp. 1041-1049 . DOI:10.1016/j.drugpo.2015.05.019
Seven years have elapsed since the Scottish Government launched its Hepatitis C Action Plan - a Plan to improve services to prevent transmission of infection, particularly among people who inject drugs (PWID), identify those infected and ensure those infected receive optimal treatment. The Plan was underpinned by industrial scale funding (around £100 million, in addition to the general NHS funding, will have been invested by 2015), and a web of accountable national and local multi-disciplinary multi-agency networks responsible for the planning, development and delivery of services. Initiatives ranged from the introduction of testing in specialist drug services through finger-prick blood sampling by non-clinical staff, to the setting of government targets to ensure rapid scale-up of antiviral therapy. The Plan was informed by comprehensive national monitoring systems, indicating the extent of the problem not just in terms of numbers infected, diagnosed and treated but also the more penetrative data on the number advancing to end-stage liver disease and death, and also through compelling modelling work demonstrating the potential beneficial impact of scaling-up therapy and the mounting cost of not acting. Achievements include around 50% increase in the proportion of the infected population diagnosed (38% to 55%); a sustained near two-and-a-half fold increase in the annual number of people initiated onto therapy (470 to 1050) with more pronounced increases among PWID (300 to 840) and prisoners (20 to 140); and reversing of an upward trend in the overall number of people living with chronic infection. The Action Plan has demonstrated that a Government-backed, coordinated and invested approach can transform services and rapidly improve the lives of thousands. Cited as "an impressive example of a national strategy" by the Global Commission on Drug Policy, the Scottish Plan has also provided fundamental insights of international relevance into the management of HCV among PWID.
In: Hutchinson , S J , Dillon , J F , Fox , R , McDonald , S A , Innes , H , Weir , A , McLeod , A , Aspinall , E J , Palmateer , N E , Taylor , A , Munro , A , Valerio , H , Brown , G & Goldberg , D 2015 , ' Expansion of HCV treatment access to people who have injected drugs through effective translation of research into public health policy : Scotland's experience ' , International Journal of Drug Policy , vol. 26 , no. 11 , pp. 1041-1049 . https://doi.org/10.1016/j.drugpo.2015.05.019
Seven years have elapsed since the Scottish Government launched its Hepatitis C Action Plan – a Plan to improve services to prevent transmission of infection, particularly among people who inject drugs (PWID), identify those infected and ensure those infected receive optimal treatment. The Plan was underpinned by industrial scale funding (around £100 million, in addition to the general NHS funding, will have been invested by 2015), and a web of accountable national and local multi-disciplinary multiagency networks responsible for the planning, development and delivery of services. Initiatives ranged from the introduction of testing in specialist drug services through finger-prick blood sampling by nonclinical staff, to the setting of government targets to ensure rapid scale-up of antiviral therapy. The Plan was informed by comprehensive national monitoring systems, indicating the extent of the problem not just in terms of numbers infected, diagnosed and treated but also the more penetrative data on the number advancing to end-stage liver disease and death, and also through compelling modelling work demonstrating the potential beneficial impact of scaling-up therapy and the mounting cost of not acting. Achievements include around 50% increase in the proportion of the infected population diagnosed (38% to 55%); a sustained near two-and-a-half fold increase in the annual number of people initiated onto therapy (470 to 1050) with more pronounced increases among PWID (300 to 840) and prisoners (20 to 140); and reversing of an upward trend in the overall number of people living with chronic infection. The Action Plan has demonstrated that a Government-backed, coordinated and invested approach can transform services and rapidly improve the lives of thousands. Cited as ''an impressive example of a national strategy'' by the Global Commission on Drug Policy, the Scottish Plan has also provided fundamental insights of international relevance into the management of HCV among PWID.
Seven years have elapsed since the Scottish Government launched its Hepatitis C Action Plan – a Plan to improve services to prevent transmission of infection, particularly among people who inject drugs (PWID), identify those infected and ensure those infected receive optimal treatment. The Plan was underpinned by industrial scale funding (around £100 million, in addition to the general NHS funding, will have been invested by 2015), and a web of accountable national and local multi-disciplinary multi-agency networks responsible for the planning, development and delivery of services. Initiatives ranged from the introduction of testing in specialist drug services through finger-prick blood sampling by non-clinical staff, to the setting of government targets to ensure rapid scale-up of antiviral therapy. The Plan was informed by comprehensive national monitoring systems, indicating the extent of the problem not just in terms of numbers infected, diagnosed and treated but also the more penetrative data on the number advancing to end-stage liver disease and death, and also through compelling modelling work demonstrating the potential beneficial impact of scaling-up therapy and the mounting cost of not acting. Achievements include around 50% increase in the proportion of the infected population diagnosed (38% to 55%); a sustained near two-and-a-half fold increase in the annual number of people initiated onto therapy (470 to 1050) with more pronounced increases among PWID (300 to 840) and prisoners (20 to 140); and reversing of an upward trend in the overall number of people living with chronic infection. The Action Plan has demonstrated that a Government-backed, coordinated and invested approach can transform services and rapidly improve the lives of thousands. Cited as "an impressive example of a national strategy" by the Global Commission on Drug Policy, the Scottish Plan has also provided fundamental insights of international relevance into the management of HCV among PWID.